Compared to normal tissues, the mRNA level of YTHDF2 was much lower in tumor tissues (Fig. 1D), among which 26 cases (26/32, 81.25%) exhibited a decreased expression (less than 0.667-fold change) (Fig. 1E). This evidence concerns the gene YTHDF2 and neoplasm.